Search research articles
Contact Us
Filters
Showing results (381-390 of 452) with videos related to
Page
of 46
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 17, 2007
Clinical trials in gynecological cancer
E L Trimble, J Davis, P Disaia, et al.
International Journal of Molecular Sciences
|
November 13, 2021
Differential Effects of Human P301L Tau Expression in Young versus Aged Mice
Holly C Hunsberger, Sharay E Setti, Carolyn C Rudy, et al.
The Journal of Small Animal Practice
|
July 3, 2015
Serum cardiac troponin I concentrations decrease following treatment of primary immune-mediated haemolytic anaemia
J A Cartwright, D J Gow, A G Gow, et al.
American Journal of Surgery
|
February 11, 1992
Can general surgeons perform colonoscopy safely?
D N Reed, J D Collins, W J Wyatt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 6, 2010
Investigator-initiated trials of targeted oncology agents: why independent research is at risk?
L Bergmann, B Berns, A G Dalgleish, et al.
Plos One
|
March 10, 2021
Argentine Black and White Tegu (Salvator merianae) can survive the winter under semi-natural conditions well beyond their current invasive range
Scott M Goetz, David A Steen, Melissa A Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 2012
Health-related quality of life in recurrent platinum-sensitive ovarian cancer--results from the CALYPSO trial
M Brundage, M Gropp, F Mefti, et al.
Radiology
|
September 11, 2010
Global trends in hybrid imaging
Hedvig Hricak, Byung Ihn Choi, Andrew M Scott, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 7, 2011
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial
L Gladieff, A Ferrero, G De Rauglaudre, et al.
Gynecologic Oncology
|
September 23, 2017
A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancer
G Rustin, I Vergote, J P Micha, et al.
Page
of 46
Search research articles
Search
Showing results (381-390 of 452) with videos related to
Sort By:
Page
of 46
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 17, 2007
Clinical trials in gynecological cancer
E L Trimble, J Davis, P Disaia, et al.
International Journal of Molecular Sciences
|
November 13, 2021
Differential Effects of Human P301L Tau Expression in Young versus Aged Mice
Holly C Hunsberger, Sharay E Setti, Carolyn C Rudy, et al.
The Journal of Small Animal Practice
|
July 3, 2015
Serum cardiac troponin I concentrations decrease following treatment of primary immune-mediated haemolytic anaemia
J A Cartwright, D J Gow, A G Gow, et al.
American Journal of Surgery
|
February 11, 1992
Can general surgeons perform colonoscopy safely?
D N Reed, J D Collins, W J Wyatt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 6, 2010
Investigator-initiated trials of targeted oncology agents: why independent research is at risk?
L Bergmann, B Berns, A G Dalgleish, et al.
Plos One
|
March 10, 2021
Argentine Black and White Tegu (Salvator merianae) can survive the winter under semi-natural conditions well beyond their current invasive range
Scott M Goetz, David A Steen, Melissa A Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 2012
Health-related quality of life in recurrent platinum-sensitive ovarian cancer--results from the CALYPSO trial
M Brundage, M Gropp, F Mefti, et al.
Radiology
|
September 11, 2010
Global trends in hybrid imaging
Hedvig Hricak, Byung Ihn Choi, Andrew M Scott, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 7, 2011
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial
L Gladieff, A Ferrero, G De Rauglaudre, et al.
Gynecologic Oncology
|
September 23, 2017
A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancer
G Rustin, I Vergote, J P Micha, et al.
Page
of 46